You just read:

Spotlight Innovation Subsidiary Celtic Biotech Iowa Receives Approval to Commence Phase I Part 2 Clinical Trial of Crotoxin

News provided by

Spotlight Innovation Inc.

Nov 10, 2016, 09:05 ET